Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. [electronic resource] by
- Diehl, V
- Franklin, J
- Hasenclever, D
- Tesch, H
- Pfreundschuh, M
- Lathan, B
- Paulus, U
- Sieber, M
- Rueffer, J U
- Sextro, M
- Engert, A
- Wolf, J
- Hermann, R
- Holmer, L
- Stappert-Jahn, U
- Winnerlein-Trump, E
- Wulf, G
- Krause, S
- Glunz, A
- von Kalle, K
- Bischoff, H
- Haedicke, C
- Duehmke, E
- Georgii, A
- Loeffler, M
Producer: 19990105
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
9.
|
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group. [electronic resource] by
- Diehl, V
- Franklin, J
- Hasenclever, D
- Tesch, H
- Pfreundschuh, M
- Lathan, B
- Paulus, U
- Sieber, M
- Rüffer, J U
- Sextro, M
- Engert, A
- Wolf, J
- Hermann, R
- Holmer, L
- Stappert-Jahn, U
- Winnerlein-Trump, E
- Wulf, G
- Krause, S
- Glunz, A
- von Kalle, K
- Bischoff, H
- Haedicke, C
- Dühmke, E
- Georgii, A
- Loeffler, M
Producer: 19990413
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 9 Suppl 5
Availability: No items available.
|